DAVA Mission Statement
To improve patient care by realizing the full potential of oncology drug development.
DAVA Oncology was founded in 2007 with a mission to facilitate successful drug development. We have created innovative solutions and services that have succeeded to accelerate the clinical development process. We strive to advance oncology patient care through knowledge-based strategic consulting, accrual enhancement initiatives and medical oncology support.
DAVA Oncology is led by a team of highly experienced senior managers, who have played an integral role in the company’s success. Their commitment to quality and innovation is unparalleled. Our team is capable and eager to lead the organization through sustained and rapid growth in our endeavors. DAVA Oncology’s senior management team brings a wealth of broad medical, scientific and business experience, with an average of over 20 years in the both the biopharmaceutical industry and clinical medicine.
Strategic Consulting: DAVA’s evidence-based strategic insights provide tools to make tactical decisions during the development of a biological substance. We offer numerous products and services customized to fit biopharmaceutical drug development needs.
Trial Acceleration: DAVA’s dedicated medical oncology team make timely clinical trial completion a reality. Whether enrollment planning and referral outreach, site identification, or protocol feasibility, DAVA has the tools a trial needs to succeed.
Since 2007, DAVA Oncology has worked with over 80 biopharmaceutical companies and contract research organizations on over 600 projects. DAVA has provided services for 16 of the top 20 biopharmaceutical companies. Our team works cohesively with clinical trial sponsors, investigators and research staff to achieve the common goal of advancement in patient care.